VT
Insider buying
Vuong Trieu bought $15K of Oncotelic Therapeutics, Inc. (OTLC) stock
Vuong Trieu, Chairman And CEO, 10% of Oncotelic Therapeutics, Inc. (OTLC), bought 335,759 shares of OTLC stock worth $15K, per an SEC Form 4 filed Jun 17, 2026.
It was an open-market purchase.
The trade happened on Jun 15, 2026, 2 days before it was made public.
- Traded
- Jun 15, 2026
- Disclosed
- Jun 17, 2026
- Filing delay
- 2 days
- Role
- Chairman And CEO, 10%
- Source
- SEC Form 4
More OTLC insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.